Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center and 2025 Influential Woman in Oncology by OncoDaily, shared a post on X:
“Excellent talk by Dr Jay Lee about preoperative attrition outcomes of patients who don’t make it to surgery after chemoIO- only 3% complete CRT- durvalumab and there is a steep decline in event free survival.”
More posts about MaTOS 2025.
